Literature DB >> 27908606

PARP1 orchestrates epigenetic events setting up chromatin domains.

Fabio Ciccarone1, Michele Zampieri2, Paola Caiafa3.   

Abstract

Epigenetic events include reversible modifications of DNA and histone tails driving chromatin organization and thus transcription. The epigenetic regulation is a highly integrated process underlying the plasticity of the genomic information both in the context of complex physiological and pathological processes. The global regulatory aspects of epigenetic events are largely unknown. PARylation and PARP1 are recently emerging as multi-level regulatory effectors that modulate the topology of chromatin by orchestrating very different processes. This review focuses in particular on the role of PARP1 in epigenetics, trying to build a comprehensive perspective of its involvement in the regulation of epigenetic modifications of histones and DNA, contextualizing it in the global organization of chromatin domains in the nucleus.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Chromatin; DNA hydroxymethylation; DNA methylation; Epigenetic regulation; Histone acetylation; Histone methylation; PARP1; PARylation

Mesh:

Substances:

Year:  2016        PMID: 27908606     DOI: 10.1016/j.semcdb.2016.11.010

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  39 in total

Review 1.  The evolving metabolic landscape of chromatin biology and epigenetics.

Authors:  Ziwei Dai; Vijyendra Ramesh; Jason W Locasale
Journal:  Nat Rev Genet       Date:  2020-09-09       Impact factor: 53.242

Review 2.  A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.

Authors:  Craig L Parfett; Daniel Desaulniers
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

3.  MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells.

Authors:  Masaaki Yamamoto; Caining Jin; Tsuyoshi Hata; Yota Yasumizu; Yan Zhang; Deli Hong; Takahiro Maeda; Masaaki Miyo; Masayuki Hiraki; Yozo Suzuki; Kunihiko Hinohara; Hasan Rajabi; Donald Kufe
Journal:  Cancer Res       Date:  2019-03-01       Impact factor: 12.701

4.  Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.

Authors:  Xiaoxiao Huang; Richard D LeDuc; Luca Fornelli; Alissa J Schunter; Richard L Bennett; Neil L Kelleher; Jonathan D Licht
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

Review 5.  PARP1-modulated chromatin remodeling is a new target for cancer treatment.

Authors:  Saptarshi Sinha; Sefinew Molla; Chanakya Nath Kundu
Journal:  Med Oncol       Date:  2021-08-25       Impact factor: 3.064

Review 6.  Pleiotropic role of PARP1: an overview.

Authors:  Vikas Kumar; Anurag Kumar; Khursheed Ul Islam Mir; Vandana Yadav; Shyam Singh Chauhan
Journal:  3 Biotech       Date:  2021-12-04       Impact factor: 2.406

Review 7.  Role of NAD+ and FAD in Ischemic Stroke Pathophysiology: An Epigenetic Nexus and Expanding Therapeutic Repertoire.

Authors:  Parimala Narne; Prakash Babu Phanithi
Journal:  Cell Mol Neurobiol       Date:  2022-09-30       Impact factor: 4.231

Review 8.  Pleiotropic roles of tankyrase/PARP proteins in the establishment and maintenance of human naïve pluripotency.

Authors:  Ludovic Zimmerlin; Elias T Zambidis
Journal:  Exp Cell Res       Date:  2020-03-07       Impact factor: 3.905

9.  Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus.

Authors:  Michele Zampieri; Maria Giulia Bacalini; Ilaria Barchetta; Stefania Scalea; Flavia Agata Cimini; Laura Bertoccini; Stefano Tagliatesta; Giovanna De Matteis; Giuseppe Zardo; Maria Gisella Cavallo; Anna Reale
Journal:  Clin Epigenetics       Date:  2021-05-17       Impact factor: 6.551

10.  Diabetes Mellitus Promotes Atrial Structural Remodeling and PARP-1/Ikkα/NF-κB Pathway Activation in Mice.

Authors:  Tianyu Meng; Jie Wang; Manyun Tang; Shangyu Liu; Ligang Ding; Yang Yan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-17       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.